Diabetic Wounds and Short-chain Fatty Acids

Overview

Journal J Diabetes Metab Disord

Date 2025 Jan 13

PMID 39801685

Authors

Zahra Rezaeiasl

Mahmoud Salami Zavareh

Affiliations

Soon will be listed here.

Abstract

Diabetes mellitus is a debilitating and worrisome chronic disease with many complications such as cardiovascular disease, kidney damage, blindness and diabetic wounds. Despite advances in the treatment of diabetic wounds, there are still concerns regarding the management of diabetic wound healing, particularly the inflammatory phase. In addition to many treatments with successful effects on wound healing in diabetic patients, short-chain fatty acids (SCFA) acetate, propionate, butyrate, valproate and valerate and their by-products have recently been proposed as new treatments for wound healing in diabetic patients. We provide an overview of the most recent studies on the effectiveness of the above-mentioned SCFAs in the treatment of diabetic wounds as well as possible effects on cytokines in this area of study.

References

Dasari N, Jiang A, Skochdopole A, Chung J, Reece E, Vorstenbosch J . Updates in Diabetic Wound Healing, Inflammation, and Scarring. Semin Plast Surg. 2021; 35(3):153-158. PMC: 8432997. DOI: 10.1055/s-0041-1731460. View

Palm N, de Zoete M, Flavell R . Immune-microbiota interactions in health and disease. Clin Immunol. 2015; 159(2):122-127. PMC: 4943041. DOI: 10.1016/j.clim.2015.05.014. View

Molinaro A, Bel Lassen P, Henricsson M, Wu H, Adriouch S, Belda E . Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology. Nat Commun. 2020; 11(1):5881. PMC: 7676231. DOI: 10.1038/s41467-020-19589-w. View

Yap Y, McLeod K, McKenzie C, Gavin P, Davalos-Salas M, Richards J . An acetate-yielding diet imprints an immune and anti-microbial programme against enteric infection. Clin Transl Immunology. 2021; 10(1):e1233. PMC: 7809703. DOI: 10.1002/cti2.1233. View

Lauterbach A, Slezak A, Wang R, Cao S, Raczy M, Watkins E . Mannose-Decorated Co-Polymer Facilitates Controlled Release of Butyrate to Accelerate Chronic Wound Healing. Adv Healthc Mater. 2023; 12(26):e2300515. PMC: 11468131. DOI: 10.1002/adhm.202300515. View

Khan R, Chua Z, Tan J, Yang Y, Liao Z, Zhao Y . From Pre-Diabetes to Diabetes: Diagnosis, Treatments and Translational Research. Medicina (Kaunas). 2019; 55(9). PMC: 6780236. DOI: 10.3390/medicina55090546. View

Monti B, Polazzi E, Contestabile A . Biochemical, molecular and epigenetic mechanisms of valproic acid neuroprotection. Curr Mol Pharmacol. 2009; 2(1):95-109. DOI: 10.2174/1874467210902010095. View

Snyder R, Lantis J, Kirsner R, Shah V, Molyneaux M, Carter M . Macrophages: A review of their role in wound healing and their therapeutic use. Wound Repair Regen. 2016; 24(4):613-29. DOI: 10.1111/wrr.12444. View

Sundaramurthi D, Krishnan U, Sethuraman S . Epidermal differentiation of stem cells on poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) nanofibers. Ann Biomed Eng. 2014; 42(12):2589-99. DOI: 10.1007/s10439-014-1124-3. View

10.

Nowak N, Menichella D, Miller R, Paller A . Cutaneous innervation in impaired diabetic wound healing. Transl Res. 2021; 236:87-108. PMC: 8380642. DOI: 10.1016/j.trsl.2021.05.003. View

11.

Gorecka J, Kostiuk V, Fereydooni A, Gonzalez L, Luo J, Dash B . The potential and limitations of induced pluripotent stem cells to achieve wound healing. Stem Cell Res Ther. 2019; 10(1):87. PMC: 6416973. DOI: 10.1186/s13287-019-1185-1. View

12.

Gothai S, Muniandy K, Zarin M, Sean T, Suresh Kumar S, Munusamy M . Chemical Composition of Ethyl Acetate Fraction and Its Biological Activity in Diabetic Human Dermal Fibroblasts. Pharmacogn Mag. 2017; 13(Suppl 3):S462-S469. PMC: 5669083. DOI: 10.4103/pm.pm_368_16. View

13.

Blakytny R, Jude E . The molecular biology of chronic wounds and delayed healing in diabetes. Diabet Med. 2006; 23(6):594-608. DOI: 10.1111/j.1464-5491.2006.01773.x. View

14.

Patel M, Patel B . Repurposing of sodium valproate in colon cancer associated with diabetes mellitus: Role of HDAC inhibition. Eur J Pharm Sci. 2018; 121:188-199. DOI: 10.1016/j.ejps.2018.05.026. View

15.

Fusco W, Lorenzo M, Cintoni M, Porcari S, Rinninella E, Kaitsas F . Short-Chain Fatty-Acid-Producing Bacteria: Key Components of the Human Gut Microbiota. Nutrients. 2023; 15(9). PMC: 10180739. DOI: 10.3390/nu15092211. View

16.

Papatheodorou K, Banach M, Bekiari E, Rizzo M, Edmonds M . Complications of Diabetes 2017. J Diabetes Res. 2018; 2018:3086167. PMC: 5866895. DOI: 10.1155/2018/3086167. View

17.

Tan J, McKenzie C, Potamitis M, Thorburn A, Mackay C, Macia L . The role of short-chain fatty acids in health and disease. Adv Immunol. 2014; 121:91-119. DOI: 10.1016/B978-0-12-800100-4.00003-9. View

18.

Tonnesen M, Feng X, Clark R . Angiogenesis in wound healing. J Investig Dermatol Symp Proc. 2001; 5(1):40-6. DOI: 10.1046/j.1087-0024.2000.00014.x. View

19.

Nirenjen S, Narayanan J, Tamilanban T, Subramaniyan V, Chitra V, Fuloria N . Exploring the contribution of pro-inflammatory cytokines to impaired wound healing in diabetes. Front Immunol. 2023; 14:1216321. PMC: 10414543. DOI: 10.3389/fimmu.2023.1216321. View

20.

Falanga V . Wound healing and its impairment in the diabetic foot. Lancet. 2005; 366(9498):1736-43. DOI: 10.1016/S0140-6736(05)67700-8. View